Ibex Investors’s Ingevity NGVT Stock Holding History

Ibex Investors’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,969	Closed	-$201K	–	219
2018 Q3	$201K	Buy	+1,969	New	+$190K	0.11%	180

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ibex Investors's NGVT Position: Q4 2018 in Review

Ibex Investors sold out of Ingevity (NGVT) in Q4 2018, closing a stake of 1,969 shares — an estimated $201K sold.

Ibex Investors first reported a position in NGVT in Q3 2018 and held it in 1 quarter. The position peaked at $201K in Q3 2018. 316 funds tracked by Wall St. Rank hold NGVT as of Q4 2018.

Ibex Investors reported no remaining Ingevity position as of Q4 2018 after selling out during the quarter.
Ibex Investors sold 1,969 Ingevity shares in Q4 2018, an estimated $201K.
Ibex Investors first reported a position in Ingevity in Q3 2018 and held it in 1 quarter.
Ibex Investors's Ingevity position peaked at $201K in Q3 2018.
316 funds tracked by Wall St. Rank held Ingevity as of Q4 2018.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.